Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension, USP 750mg/5mL due to Potential Bacillus cereus Contamination in the Product
/PRNewswire/ -- Camber Pharmaceuticals, Inc. is voluntarily recalling lot # E220182 of Atovaquone Oral Suspension, USP 750mg/5mL to the Consumer/User level,...
Camber Pharmaceuticals Inc Company Contact Drug Administration Inmar Return Services Logistics Company Prnewswire Camber Pharmaceuticals Inc
Source: prnewswire.com